Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.
暂无分享，去创建一个
D. Planchard | N. Chaput | F. Barlesi | B. Besse | A. Levy | M. Tagliamento | C. Naltet | M. Aldea | A. Botticella | E. Auclin | P. Lavaud | M. Frelaut | J. Benítez | M. Grecea | Adrien Rousseau | J. Benitez